Differential expression of lysophosphatidic acid receptor-2 in intestinal and diffuse type gastric cancer

Journal of Surgical Oncology

Volumn 93, Issue 1, 2006, Pages 30-35

  Yamashita, Hiroharu ^a,b   Kitayama, Joji ^a   Shida, Dai ^a   Ishikawa, Makoto ^a   Hama, Kotaro ^b   Aoki, Junken ^b   Arai, Hiroyuki ^b   Nagawa, Hirokazu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Gastric cancer; LPA2; Lysophosphatidic acid

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR 2; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INVASION; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; STOMACH CARCINOGENESIS; TISSUE DISTRIBUTION;

ADENOCARCINOMA; AGED; CARCINOMA, SIGNET RING CELL; FEMALE; GASTRECTOMY; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; RECEPTORS, LYSOPHOSPHATIDIC ACID; STOMACH NEOPLASMS;

EID: 29844437521     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20397     Document Type: Article

References (29)

1. Moolenaar WH: Bioactive lysophospholipids and their G protein-coupled receptors. Exp Cell Res 1999;253:230-238.
2. Mills GB, Moolenaar WH: The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer 2003;3:582-591.
3. Contos JJ, Fukushima N, Weiner JA, et al.: Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior. Proc Natl Acad Sci USA 2000;97:13384-13389.
4. Contos JJ, Ishii I, Fukushima N, et al.: Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: Signaling deficits without obvious phenotypic abnormality attributable to lpa(2). Mol Cell Biol 2002;22: 6921-6929.
5. Hama K, Aoki J, Fukaya M, et al.: Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1. J Biol Chem 2004;279:17634-17639.
6. Inoue M, Rashid MH, Fujita R, et al.: Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nat Med 2004;10:712-718.
7. Contos JJ, Ishii I, Chun J: Lysophosphatidic acid receptors. Mol Pharmacol 2000;58:1188-1196.
8. An S, Bleu T, Hallmark OG, Goetzl EJ: Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid. J Biol Chem 1998;273:7906-7910.
9. Bandoh K, Aoki J, Hosono H, et al.: Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J Biol Chem 1999;274:27776-27785.
10. Fujita T, Miyamoto S, Onoyama I, et al.: Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer. Cancer Lett 2003;192:161-169.
11. Fang X, Schummer M, Mao M, et al.: Lysophosphatidic acid is a bioactive mediator in ovarian cancer. Biochim Biophys Acta 2002;1582:257-264.
12. Schulte KM, Beyer A, Kohrer K, et al.: Lysophosphatidic acid, a novel lipid growth factor for human thyroid cells: Overexpression of the high-affinity receptor edg4 in differentiated thyroid cancer. Int J Cancer 2001;92:249-256.
13. Shida D, Watanabe T, Aoki J, et al.: Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer. Lab Invest 2004;84:1352-1362.
14. Kitayama J, Shida D, Sako A, et al.: Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma. Breast Cancer Res 2004;6:R640-646.
15. Japanese Gastric Cancer A: Japanese classification of gastric carcinoma-2nd English edition. Gastric Cancer 1998;1:10-24.
16. Contos JJ, Chun J: Genomic characterization of the lysophosphatidic acid receptor gene, lp(A2)/Edg4, and identification of a frameshift mutation in a previously characterized cDNA. Genomics 2000;64:155-169.
17. Shida D, Kitayama J, Yamaguchi H, et al.: Dual mode regulation of migration by lysophosphatidic acid in human gastric cancer cells. Exp Cell Res 2004.
18. Tokunaga A, Onda M, Okuda T, et al.: Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer. Cancer 1995;75:1418-1425.
19. Sakai K, Mori S, Kawamoto T, et al.: Expression of epidermal growth factor receptors on normal human gastric epithelia and gastric carcinomas. J Natl Cancer Inst 1986;77:1047-1052.
20. Pfeiffer A, Rothbauer E, Wiebecke B, et al.: Increased epidermal growth factor receptors in gastric carcinomas. Gastroenterology 1990;98:961-967.
21. Garcia I, Vizoso F, Martin A, et al.: Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer. Ann Surg Oncol 2003;10:234-241.
22. Coyle WJ, Sedlack RE, Nemec R, et al.: Eradication of Helicobacter pylori normalizes elevated mucosal levels of epidermal growth factor and its receptor. Am J Gastroenterol 1999;94:2885-2889.
23. Wallasch C, Crabtree JE, Bevec D, et al.: Helicobacter pylori-stimulated EGF receptor transactivation requires metalloprotease cleavage of HB-EGF. Biochem Biophys Res Commun 2002; 295:695-701.
24. Uemura N, Okamoto S, Yamamoto S, et al.: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-789.
25. Correa P: Human gastric carcinogenesis: A multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992;52:6735-6740.
26. Sipponen P, Kosunen TU, Valle J, et al.: Helicobacter pylori infection and chronic gastritis in gastric cancer. J Clin Pathol 1992;45:319-323.
27. Solcia E, Fiocca R, Luinetti O, et al.: Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement. Am J Surg Pathol 1996;20(Suppl 1):S8-22.
28. Murakami N, Koufuji K, Shirouzu K: Influence of hepatocyte growth factor secreted from fibroblasts on the growth and invasion of scirrhous gastric cancer. Int Surg 2001;86:151-157.
29. Churin Y, Al-Ghoul L, Kepp O, et al.: Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response. J Cell Biol 2003;161:249-255.